An interesting study showed that Tofacitinib (JAK/STAT inhibitor) significantly increased oxidative phosphorylation, ATP production, and the maximal respiratory capacity and the respiratory reserve in RA synovial fibroblasts, an effect paralleled by a decrease in glycolysis and glycolytic enzymes such as HK2, GSK-3α, lactate dehydrogenase A, HIF1α (40). This evidence concerns the gene LDHA and rheumatoid arthritis.